Advertisement
Screener

Exelixis Inc (EXEL) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Exelixis Inc Cash Flow Breakdown

Cash flow breakdown shows where Exelixis Inc's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2026-01-02: from running the business, $884.27M came in.
  • Fiscal year ended 2026-01-02: from investing, $350.44M came in.
  • Fiscal year ended 2026-01-02: from financing, $969.59M went out.
  • Fiscal year ended 2026-01-02: change in cash, $265.11M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backNew debtStaff share taxNew shares soldOtherNot split outChange in cash
2026-01-02$884.27M$350.44M-$947.51M-$71.22M$49.14M*$265.11M
2025-01-03$699.97M-$116.78M-$652.03M-$38.63M$61.85M*-$45.62M
2023-12-29$333.32M-$26.95M-$550.38M-$29.12M$33.45M*-$239.68M
2022-12-30$362.61M-$524.41M$0.00-$23.30M$23.89M*-$161.21M
2021-12-31$400.80M-$42.88M$0.00-$39.11M$0.00$24.31M*$343.12M
2021-01-01$208.98M-$131.22M-$50.02M$0.00$24.89M*$52.63M
2020-01-03$526.96M-$587.25M$0.00-$9.90M-$42.00K$22.50M*-$47.74M
2018-12-28$415.72M-$297.85M$0.00-$7.57M$12.08M-$13.00K$5.20M*$127.56M
2017-12-29$165.61M$36.80M-$185.79M-$6.56M$0.00$0.00$22.42M*$32.48M
2016-12-31$206.30M-$216.05M$0.00$19.80M*$10.05M
2016-12-30$210.40M-$214.55M-$575.00K-$4.11M$25.33M-$4.95M*$11.55M
2016-01-01-$141.05M$50.08M-$4.38M-$534.00K$145.65M$11.48M*$61.24M
2015-12-31-$141.59M$50.08M$145.65M$7.10M*$61.24M
2014-12-31-$235.41M$146.33M$0.00$75.64M-$10.15M*-$23.58M
2013-12-31-$198.77M$144.35M$0.00$0.00-$11.67M*-$66.09M
2012-12-31-$123.15M-$259.47M$277.67M$203.48M-$2.72M*$95.81M
2011-12-31-$159.23M-$51.46M$2.59M$179.38M$5.55M*-$23.18M
2010-12-31-$101.05M-$19.57M$165.01M$0.00-$33.75M*$10.64M
2009-12-31-$14.59M-$112.32M-$33.99M*-$160.90M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backNew debtStaff share taxNew shares soldOtherNot split outChange in cash
2026-07-03$307.74M*$91.43M*-$322.97M*-$36.34M*$15.44M*
2026-04-03$251.84M-$51.07M-$430.35M-$34.23M$7.47M*-$256.34M
2026-01-02$333.51M*$27.24M*-$257.62M*-$4.83M*$7.88M*
2025-10-03$290.32M*$25.41M*-$104.03M*-$3.38M*
2025-07-04$48.99M*$248.03M*-$301.92M*-$40.50M*$26.08M*
2025-04-04$211.44M$49.76M-$283.93M-$22.52M$11.63M*-$33.62M
2025-01-03$240.26M*-$93.20M*-$190.41M*-$16.45M*$18.82M*
2024-09-27$271.34M*-$217.15M*-$11.93M*-$2.17M*$19.79M*
2024-06-28$119.55M*$81.77M*-$264.32M*-$13.03M*$14.92M*
2024-03-29$68.82M$111.79M-$185.38M-$6.99M$8.31M*-$3.43M
2023-12-29$10.57M*$61.74M*-$209.30M*-$5.99M*$9.11M*
2023-09-29$117.37M*$34.69M*-$216.84M*-$9.75M*$6.92M*
2023-06-30$120.98M*-$73.78M*-$124.24M*-$10.83M*$10.28M*
2023-03-31$84.41M-$49.59M$0.00-$2.56M$7.14M*$39.40M
2022-12-30$73.69M*-$245.78M*$0.00*-$7.21M*$5.21M*
2022-09-30$110.07M*-$68.95M*$0.00*-$4.93M*$2.89M*
2022-07-01$31.13M*-$135.14M*-$6.48M*$10.90M*
2022-04-01$147.72M-$74.54M-$4.69M*$73.39M
2021-12-31$96.45M*-$13.05M*-$24.06M*$6.07M*
2021-10-01$83.31M*-$21.24M*-$5.64M*$2.75M*
2021-07-02$181.50M*-$70.84M*-$3.97M*$12.70M*
2021-04-02$39.54M$62.26M-$5.44M$2.79M*$99.15M
2021-01-01$33.29M*-$29.51M*-$23.90M*$0.00*$5.20M*
2020-10-02$17.94M*-$207.60M*-$5.18M*$0.00*$1.74M*
2020-07-03$101.68M*$73.27M*-$19.15M*$0.00*$14.00M*
2020-04-03$56.07M$32.62M-$1.79M$0.00$3.94M*$90.84M
2020-01-03$158.02M*-$130.20M*-$6.54M*-$8.00K*$3.54M*
2019-09-27$75.61M*-$206.46M*-$935.00K*$4.22M*-$12.00K*
2019-06-28$131.73M*-$142.93M*-$854.00K*$3.77M*-$11.00K*$4.14M*
2019-03-29$161.59M-$107.66M-$1.58M$6.82M-$11.00K$59.16M
2018-12-28$104.59M*-$142.80M*$0.00*-$4.37M*$1.69M*$1.54M*
2018-09-28$164.86M*-$63.25M*$0.00*-$229.00K*$3.84M*
2018-06-29$74.47M*-$66.27M*$0.00*-$847.00K*$4.67M*$3.65M*
2018-03-30$71.81M-$25.53M$0.00-$2.13M$1.88M$46.02M
2017-12-29$53.35M*-$18.33M*$0.00*-$3.55M*$1.02M*$1.81M*$33.81M*
2017-09-30$37.87M*-$26.59M*$0.00*-$681.00K*$3.55M*$14.14M*
2017-09-29$37.87M*-$26.59M*$0.00*-$681.00K*$3.55M*
2017-06-30$5.54M*$46.72M*-$105.79M*-$788.00K*$3.31M*$3.05M*-$47.97M*
2017-03-31$68.86M$34.50M-$80.00M-$1.54M$9.68M$31.49M
2016-12-31$81.00M*-$60.41M*$0.00*$19.88M*$40.47M*
2016-09-30-$5.78M*-$12.13M*$0.00*-$654.00K*$7.09M*-$18.61M*
2016-06-30-$25.73M*-$123.83M*-$145.00K*$2.17M*-$147.06M*
2016-03-31$156.81M-$19.68M-$1.91M$37.00K$135.25M
2015-12-31-$35.43M*$24.01M*-$2.00K*$7.42M*-$4.01M*
2015-09-30-$34.23M*-$31.51M*$145.65M*$3.79M*$83.69M*
2015-06-30-$26.83M*$7.68M*$0.00*-$3.89M*-$23.04M*
2015-03-31-$45.09M$49.90M$0.00$4.59M
2014-12-31-$49.98M*$30.18M*-$3.00K*-$19.67M*
2014-09-30-$58.01M*$11.11M*$0.00*-$47.27M*
2014-06-30-$55.34M*$44.69M*$0.00*-$10.20M*
2014-03-31-$72.09M$60.36M$75.65M-$10.36M*$53.56M
2013-12-31-$47.33M*$59.51M*$0.00*$0.00*$11.96M*
2013-09-30-$56.99M*$18.03M*$0.00*-$789.00K*-$39.76M*
2013-06-30-$40.03M*$467.00K*$0.00*-$39.46M*
2013-03-31-$54.41M$66.35M$0.00-$10.78M*$1.16M
2012-12-31-$38.74M*-$99.63M*$0.00*$0.00*-$138.74M*
2012-09-30-$34.05M*-$141.21M*$277.67M*$138.44M*$240.66M*
2012-06-30-$35.39M*$33.64M*$46.00K*-$624.00K*-$2.33M*
2012-03-31-$14.97M-$52.28M$64.99M-$1.54M*-$3.79M
2011-12-31-$29.17M*$37.38M*$0.00*-$2.00K*$8.05M*
2011-09-30-$43.27M*$32.56M*$0.00*$0.00*$1.64M*-$9.07M*
2011-06-30-$43.52M*-$89.89M*$30.00K*$6.61M*-$126.77M*
2011-03-31-$43.28M-$31.50M$179.35M$104.61M
2010-12-31$21.25M*$6.39M*-$25.55M*$2.10M*
2010-09-30-$43.83M*-$15.19M*-$2.84M*-$61.86M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78